---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-106685"
form_type: "8-K"
ticker: "LQDA"
cik: "0001819576"
company_name: "Liquidia Corp"
filed_at: "2024-10-07T23:59:59+00:00"
generated_at: "2026-05-30T19:26:58.785393+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Supreme Court denies United Therapeutics' certiorari; Liquidia's '793 patent invalid final

## Summary
- Supreme Court rejected UTHR's cert petition, finalizing PTAB and Federal Circuit rulings that all claims of U.S. Patent No. 10,716,793 are invalid.
- No valid claims of the three patents originally asserted by UTHR found infringed; all decisions final and not subject to further appeal.
- FDA granted tentative approval of YUTREPIA for PAH and PH-ILD on Aug 16, 2024; final approval may occur after May 23, 2025.
- U.S. District Court denied UTHR's preliminary injunction on '327 patent; trial scheduled for June 2025.

## SEC filing metadata
- accession: 0001104659-24-106685
- form_type: 8-K
- ticker: LQDA
- cik: 0001819576
- company_name: Liquidia Corp
- filed_at: 2024-10-07T23:59:59+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819576/000110465924106685/0001104659-24-106685-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819576/000110465924106685/tm2425742d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-106685
- JSON: https://secwatch.observer/filing/0001104659-24-106685.json
- Plain text: https://secwatch.observer/filing/0001104659-24-106685.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.